Nimish Vakil
Nimish Vakil
Proton pump inhibitors (PPIs) are currently the most effective and most widely used agents for gastroesophageal reflux disease (GERD). Despite the efficacy of these agents in healing and symptom relief, a substantial proportion of patients ...
Shani Desilva,Gil Kaplan,Remo Panaccione
Shani Desilva
The current guidelines for the management of Crohn's disease (CD) suggest a stepwise approach to treatment according to the severity of clinical presentation. The use of tumor necrosis factor (TNF) antagonists are currently reserved for pat...
David A Johnson,Philip O Katz
David A Johnson
The consequences of nocturnal gastroesophageal reflux disease (GERD) may be greater than daytime GERD in terms of clinical complications such as increased risk of esophageal lesions and respiratory conditions, as well as issues of health-re...
Kapil Gupta,Martin L Freeman
Kapil Gupta
Self-expanding metal stents (SEMS) have changed the management of malignant gastrointestinal obstruction. In malignant gastroduodenal obstruction for which curative surgical resection is not possible, endoscopic placement of SEMS is an idea...
Nimish Vakil
Nimish Vakil
Clarithromycin resistance is a growing problem in many countries. Eradication rates for Helicobacter pylori have declined to unacceptable levels in recent years, in large measure because of clarithromycin resistance. Two treatment strategie...
Edward C Oldfield rd
Edward C Oldfield rd
Esophageal disease. Intragastric pH control and healing of erosive esophagitis [0.03%]
食管疾病。胃内pH控制和反流性食管炎的愈合
Philip O Katz
Philip O Katz
Infectious disease. Endocarditis prophylaxis: new guideline, much less antibiotic prophylaxis [0.03%]
感染病·心内膜炎的预防：新的指南大幅减少抗生素预防措施
Edward C Oldfield rd
Edward C Oldfield rd
Danial E Baker
Danial E Baker
In 2007, the American College of Gastroenterology published updated treatment guidelines for the management of Helicobacter pylori infection, the leading cause of peptic ulcers. The recommended effective therapies are a triple drug regimen ...